Play

ANCHOR LEAD: HOW MANY DEATHS ARE DUE TO CIGARETTE SMOKING? ELIZABETH TRACEY REPORTS

On the fiftieth anniversary of the first surgeon general’s report on the health impact of cigarette smoking, the Journal of the American Medical Association published a comprehensive look at where we are today. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the sobering statistics.

[click to continue…]

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

ANCHOR LEAD: AN UNSUSPECTED TARGET MORPHS IN MANY BREAST CANCERS, ELIZABETH TRACEY REPORTS

Many breast cancers are dependent on the hormone estrogen and have receptors for it, previously thought not to undergo much change as cancers progress. Now Ben Park, a breast cancer expert at Johns Hopkins, says new research finds that the receptor does change.

PARK: Women who have estrogen-receptor positive disease who recur on hormonal therapies, there’s a pretty high percentage of those women who actually develop mutations in the estrogen receptor in their tumor, and that is a mechanism of resistance that heretofore was really not thought of to be a mechanism, so the estrogen receptor is a target, we can interfere with that mechanism with the hormone therapies that we currently have, but because of the genetic slipperiness or instability of cancers, eventually the cancers learn to evade that hormone therapy by mutating the estrogen receptor. :32

Park says this finding will likely impact the choice of therapies. At Johns Hopkins, I’m Elizabeth Tracey.

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

ANCHOR LEAD: WILL REQUIRING PEOPLE TO BE 21 BEFORE THEY CAN PURCHASE
CIGARETTES CURB THE HABIT? ELIZABETH TRACEY REPORTS

People must be 21 years of age or older in order to purchase cigarettes in New York City, the latest of laws related to improving health mandates there. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says such laws are already in place elsewhere in the nation, and he’s in favor.
[click to continue…]

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

ANCHOR LEAD: HAS TOO MUCH RESTRICTION OF THE PHARMA/ACADEMIA RELATIONSHIP BEEN IMPOSED? ELIZABETH TRACEY REPORTS

The FDA now regulates how pharmaceutical companies interact with academic institutions, with an eye toward preserving objectivity on the part of researchers. Ben Park, a cancer researcher at Johns Hopkins, says it is possible for such an undertaking to go too far.

[click to continue…]

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

This week’s topics include mortality and timing of MI, new antibody treatments for Alzheimer’s disease, handguns and homicide and suicide, and vitamin D levels and MS.

Download PDF Transcript

Related Article: Alzheimer’s and Amyloid

 

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

ANCHOR LEAD: WILL INDUSTRY/ACADEMIC PARTNERSHIPS IMPERIL TRUST? ELIZABETH TRACEY
REPORTS

Industry often engages academic institutions, Johns Hopkins among them, to study their drugs, products or devices, and this is an important source of funding. Ben Park, a cancer researcher at Hopkins, says he opts for full disclosure so patients feel they’ve been fully informed.

[click to continue…]

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Play

ANCHOR LEAD: GROUPS LIKE STAND UP TO CANCER ARE VERY HELPFUL IN MOVING THE RESEARCH
ENTERPRISE FORWARD, ELIZABETH TRACEY REPORTS

What do major league baseball, the organization known as Stand Up to Cancer, and Johns Hopkins have in common? They’re all involved in helping raise funds for research to combat cancer, with baseball owners recently providing auction items to assist fundraising efforts. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says such strategies are now more important than ever.

[click to continue…]

VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)